메뉴 건너뛰기




Volumn 90, Issue 3, 2008, Pages

Levosimendan use in several scenarios of acute heart failure;Uso de levosimendana em diversos quadros de insuficiência cardíaca aguda

Author keywords

Acute heart failure therapy; Inodilators; Inotropes; Levosimendan

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM SENSITIZER; DOBUTAMINE; LEVOSIMENDAN; MAGNESIUM; NORADRENALIN; POTASSIUM;

EID: 42049103033     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008000300012     Document Type: Review
Times cited : (10)

References (63)
  • 1
    • 33644808285 scopus 로고    scopus 로고
    • Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology
    • Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology. Kardiol Pol. 2005; 63: 143-86.
    • (2005) Kardiol Pol , vol.63 , pp. 143-186
    • Nieminen, M.S.1    Bohm, M.2    Cowie, M.R.3    Drexler, H.4    Filippatos, G.S.5    Jondeau, G.6
  • 2
    • 0036169238 scopus 로고    scopus 로고
    • Management of heart failure in the elderly
    • Rich MW, Management of heart failure in the elderly. Heart Fail Rev. 2002; 7 (1): 89-97.
    • (2002) Heart Fail Rev , vol.7 , Issue.1 , pp. 89-97
    • Rich, M.W.1
  • 3
    • 33644849222 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113: e85-151.
    • (2006) Circulation , vol.113
    • Thom, T.1    Haase, N.2    Rosamond, W.3    Howard, V.J.4    Rumsfeld, J.5    Manolio, T.6
  • 4
    • 37549034629 scopus 로고    scopus 로고
    • Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes
    • in press
    • Mebazaa A, Gheorghiade M, Piña I, Harjola VP, Hollenberg S, Follath F, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med. 2008; in press.
    • (2008) Crit Care Med
    • Mebazaa, A.1    Gheorghiade, M.2    Piña, I.3    Harjola, V.P.4    Hollenberg, S.5    Follath, F.6
  • 5
    • 30444441774 scopus 로고    scopus 로고
    • Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study
    • Zannad F, Mebazaa A, Juilliere Y, Cohen-Solal A, Guize L, Alla F, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail. 2006; 8: 697-705.
    • (2006) Eur J Heart Fail , vol.8 , pp. 697-705
    • Zannad, F.1    Mebazaa, A.2    Juilliere, Y.3    Cohen-Solal, A.4    Guize, L.5    Alla, F.6
  • 6
    • 33750731595 scopus 로고    scopus 로고
    • Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
    • Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006; 296: 2217-26.
    • (2006) JAMA , vol.296 , pp. 2217-2226
    • Gheorghiade, M.1    Abraham, W.T.2    Albert, N.M.3    Greenberg, B.H.4    O'Connor, C.M.5    She, L.6
  • 7
    • 29444454634 scopus 로고    scopus 로고
    • Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE
    • Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail. 2006; 8: 105-10.
    • (2006) Eur J Heart Fail , vol.8 , pp. 105-110
    • Cleland, J.G.1    Freemantle, N.2    Coletta, A.P.3    Clark, A.L.4
  • 8
    • 0033970796 scopus 로고    scopus 로고
    • Rationale and design of the OPTIME CHF trial: Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure
    • Cuffe MS, Califf RM, Adams KF, Bourge RC, Colucci W, Massie B, et al. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. Am Heart J. 2000; 139: 15-22.
    • (2000) Am Heart J , vol.139 , pp. 15-22
    • Cuffe, M.S.1    Califf, R.M.2    Adams, K.F.3    Bourge, R.C.4    Colucci, W.5    Massie, B.6
  • 9
    • 0037181515 scopus 로고    scopus 로고
    • Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial
    • Cuffe MS, Califf RM, Adams KF Jr., Benza R, Bourge R, Colucci WS, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002; 287: 1541-7.
    • (2002) JAMA , vol.287 , pp. 1541-1547
    • Cuffe, M.S.1    Califf, R.M.2    Adams Jr., K.F.3    Benza, R.4    Bourge, R.5    Colucci, W.S.6
  • 12
    • 33645498542 scopus 로고    scopus 로고
    • Levosimendan, a new inotropic and vasodilator agent
    • Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology. 2006; 104: 556-69.
    • (2006) Anesthesiology , vol.104 , pp. 556-569
    • Toller, W.G.1    Stranz, C.2
  • 13
    • 20044379730 scopus 로고    scopus 로고
    • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
    • Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005; 26: 384-416.
    • (2005) Eur Heart J , vol.26 , pp. 384-416
    • Nieminen, M.S.1    Bohm, M.2    Cowie, M.R.3    Drexler, H.4    Filippatos, G.S.5    Jondeau, G.6
  • 14
    • 33644997173 scopus 로고    scopus 로고
    • Mechanisms and use of calcium-sensitizing agents in the failing heart
    • Kass DA, Solaro RJ. Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation. 2006; 113: 305-15.
    • (2006) Circulation , vol.113 , pp. 305-315
    • Kass, D.A.1    Solaro, R.J.2
  • 15
    • 0032541979 scopus 로고    scopus 로고
    • Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium
    • Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation. 1998; 98: 2141-7.
    • (1998) Circulation , vol.98 , pp. 2141-2147
    • Hasenfuss, G.1    Pieske, B.2    Castell, M.3    Kretschmann, B.4    Maier, L.S.5    Just, H.6
  • 16
    • 0030909430 scopus 로고    scopus 로고
    • Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers
    • Ukkonen H, Saraste M, Akkila J, Knuuti MJ, Lehikoinen P, Nagren K, et al. Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Ther. 1997; 61: 596-607.
    • (1997) Clin Pharmacol Ther , vol.61 , pp. 596-607
    • Ukkonen, H.1    Saraste, M.2    Akkila, J.3    Knuuti, M.J.4    Lehikoinen, P.5    Nagren, K.6
  • 18
    • 0034739460 scopus 로고    scopus 로고
    • Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation. 2000; 102: 2222-7.
    • Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation. 2000; 102: 2222-7.
  • 19
    • 0029788449 scopus 로고    scopus 로고
    • Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs
    • Pagel PS, Hettrick DA, Warltier DC. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol. 1996; 119: 609-15.
    • (1996) Br J Pharmacol , vol.119 , pp. 609-615
    • Pagel, P.S.1    Hettrick, D.A.2    Warltier, D.C.3
  • 20
    • 16344362711 scopus 로고    scopus 로고
    • Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake
    • Michaels AD, McKeown B, Kostal M, Vakharia KT, Jordan MV, Gerber IL, et al. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation. 2005; 111: 1504-9.
    • (2005) Circulation , vol.111 , pp. 1504-1509
    • Michaels, A.D.1    McKeown, B.2    Kostal, M.3    Vakharia, K.T.4    Jordan, M.V.5    Gerber, I.L.6
  • 21
    • 0035088001 scopus 로고    scopus 로고
    • Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels
    • Kaheinen P, Pollesello P, Levijoki J, Haikala H. Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. J Cardiovasc Pharmacol. 2001; 37: 367-74.
    • (2001) J Cardiovasc Pharmacol , vol.37 , pp. 367-374
    • Kaheinen, P.1    Pollesello, P.2    Levijoki, J.3    Haikala, H.4
  • 25
    • 0029776380 scopus 로고    scopus 로고
    • Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency
    • Pagel PS, Hettrick DA, Warltier DC. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. Basic Res Cardiol. 1996; 91: 296-307.
    • (1996) Basic Res Cardiol , vol.91 , pp. 296-307
    • Pagel, P.S.1    Hettrick, D.A.2    Warltier, D.C.3
  • 26
    • 0343049171 scopus 로고    scopus 로고
    • Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein
    • Pataricza J, Hohn J, Petri A, Balogh A, Papp JG. Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein. J Pharm Pharmacol. 2000; 52: 213-7.
    • (2000) J Pharm Pharmacol , vol.52 , pp. 213-217
    • Pataricza, J.1    Hohn, J.2    Petri, A.3    Balogh, A.4    Papp, J.G.5
  • 27
    • 0030608872 scopus 로고    scopus 로고
    • Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes
    • Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol. 1997; 333: 249-59.
    • (1997) Eur J Pharmacol , vol.333 , pp. 249-259
    • Yokoshiki, H.1    Katsube, Y.2    Sunagawa, M.3    Sperelakis, N.4
  • 28
    • 0141621300 scopus 로고    scopus 로고
    • Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery
    • Pataricza J, Krassoi I, Hohn J, Kun A, Papp JG. Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery. Cardiovasc Drugs Ther. 2003; 17: 115-21.
    • (2003) Cardiovasc Drugs Ther , vol.17 , pp. 115-121
    • Pataricza, J.1    Krassoi, I.2    Hohn, J.3    Kun, A.4    Papp, J.G.5
  • 30
    • 33747456675 scopus 로고    scopus 로고
    • Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study
    • Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med. 2006; 34: 2287-93.
    • (2006) Crit Care Med , vol.34 , pp. 2287-2293
    • Morelli, A.1    Teboul, J.L.2    Maggiore, S.M.3    Vieillard-Baron, A.4    Rocco, M.5    Conti, G.6
  • 31
    • 33750224985 scopus 로고    scopus 로고
    • Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure
    • Kerbaul F, Rondelet B, Demester JP, Fesler P, Huez S, Naeije R, et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med. 2006; 34: 2814-9.
    • (2006) Crit Care Med , vol.34 , pp. 2814-2819
    • Kerbaul, F.1    Rondelet, B.2    Demester, J.P.3    Fesler, P.4    Huez, S.5    Naeije, R.6
  • 32
    • 0036795429 scopus 로고    scopus 로고
    • Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure
    • Kivikko M, Antila S, Eha J, Lehtonen L, Pentikainen PJ. Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure. Int J Clin Pharmacol Ther. 2002; 40: 465-71.
    • (2002) Int J Clin Pharmacol Ther , vol.40 , pp. 465-471
    • Kivikko, M.1    Antila, S.2    Eha, J.3    Lehtonen, L.4    Pentikainen, P.J.5
  • 33
    • 33847028846 scopus 로고    scopus 로고
    • The utility of levosimendan in the treatment of heart failure
    • Lehtonen L, Poder P. The utility of levosimendan in the treatment of heart failure. Ann Med. 2007; 39: 2-17.
    • (2007) Ann Med , vol.39 , pp. 2-17
    • Lehtonen, L.1    Poder, P.2
  • 34
    • 33947217771 scopus 로고    scopus 로고
    • Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites
    • Puttonen J, Kantele S, Kivikko M, Hakkinen S, Harjola VP, Koskinen P, et al. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites. Clin Pharmacokinet. 2007; 46: 235-46.
    • (2007) Clin Pharmacokinet , vol.46 , pp. 235-246
    • Puttonen, J.1    Kantele, S.2    Kivikko, M.3    Hakkinen, S.4    Harjola, V.P.5    Koskinen, P.6
  • 35
    • 0037422531 scopus 로고    scopus 로고
    • Sustained hemodynamic effects of intravenous levosimendan
    • Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan. Circulation. 2003; 107: 81-6.
    • (2003) Circulation , vol.107 , pp. 81-86
    • Kivikko, M.1    Lehtonen, L.2    Colucci, W.S.3
  • 37
    • 0037142946 scopus 로고    scopus 로고
    • Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial
    • Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002; 360: 196-202.
    • (2002) Lancet , vol.360 , pp. 196-202
    • Follath, F.1    Cleland, J.G.2    Just, H.3    Papp, J.G.4    Scholz, H.5    Peuhkurinen, K.6
  • 38
    • 34547442389 scopus 로고    scopus 로고
    • Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation
    • Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation. J Card Fail. 2007; 13: 417-21.
    • (2007) J Card Fail , vol.13 , pp. 417-421
    • Zemljic, G.1    Bunc, M.2    Yazdanbakhsh, A.P.3    Vrtovec, B.4
  • 39
    • 0037001566 scopus 로고    scopus 로고
    • Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs
    • Tassani P, Schad H, Heimisch W, Bernhard-Abt A, Ettner U, Mendler N, et al. Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs. Cardiovasc Drugs Ther. 2002; 16: 435-41.
    • (2002) Cardiovasc Drugs Ther , vol.16 , pp. 435-441
    • Tassani, P.1    Schad, H.2    Heimisch, W.3    Bernhard-Abt, A.4    Ettner, U.5    Mendler, N.6
  • 41
    • 24344455110 scopus 로고    scopus 로고
    • Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig
    • Grossini E, Caimmi PP, Molinari C, Teodori G, Vacca G. Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig. J Cardiovasc Pharmacol. 2005; 46: 333-42.
    • (2005) J Cardiovasc Pharmacol , vol.46 , pp. 333-342
    • Grossini, E.1    Caimmi, P.P.2    Molinari, C.3    Teodori, G.4    Vacca, G.5
  • 42
    • 24944553441 scopus 로고    scopus 로고
    • Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction
    • De Luca L, Proietti P, Celotto A, Bucciarelli-Ducci C, Benedetti G, Di Roma A, et al. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction. Am Heart J. 2005; 150: 563-8.
    • (2005) Am Heart J , vol.150 , pp. 563-568
    • De Luca, L.1    Proietti, P.2    Celotto, A.3    Bucciarelli-Ducci, C.4    Benedetti, G.5    Di Roma, A.6
  • 43
    • 0033959417 scopus 로고    scopus 로고
    • Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels
    • Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg. 2000; 90: 5-11.
    • (2000) Anesth Analg , vol.90 , pp. 5-11
    • Kersten, J.R.1    Montgomery, M.W.2    Pagel, P.S.3    Warltier, D.C.4
  • 44
    • 0031976338 scopus 로고    scopus 로고
    • Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting
    • Lilleberg J, Nieminen MS, Akkila J, Heikkila L, Kuitunen A, Lehtonen L, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998; 19: 660-8.
    • (1998) Eur Heart J , vol.19 , pp. 660-668
    • Lilleberg, J.1    Nieminen, M.S.2    Akkila, J.3    Heikkila, L.4    Kuitunen, A.5    Lehtonen, L.6
  • 45
    • 0029097331 scopus 로고
    • Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs
    • Harkin CP, Pagel PS, Tessmer JP, Warltier DC. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. J Cardiovasc Pharmacol. 1995; 26: 179-88.
    • (1995) J Cardiovasc Pharmacol , vol.26 , pp. 179-188
    • Harkin, C.P.1    Pagel, P.S.2    Tessmer, J.P.3    Warltier, D.C.4
  • 46
    • 0034769061 scopus 로고    scopus 로고
    • Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model
    • du Toit E, Hofmann D, McCarthy J, Pineda C. Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model. Heart. 2001; 86: 81-7.
    • (2001) Heart , vol.86 , pp. 81-87
    • du Toit, E.1    Hofmann, D.2    McCarthy, J.3    Pineda, C.4
  • 47
    • 31944443341 scopus 로고    scopus 로고
    • Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: A Doppler echocardiographic study
    • De Luca L, Sardella G, Proietti P, Battagliese A, Benedetti G, Di Roma A, et al. Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study. J Am Soc Echocardiogr. 2006; 19: 172-7.
    • (2006) J Am Soc Echocardiogr , vol.19 , pp. 172-177
    • De Luca, L.1    Sardella, G.2    Proietti, P.3    Battagliese, A.4    Benedetti, G.5    Di Roma, A.6
  • 48
    • 34247341002 scopus 로고    scopus 로고
    • Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone
    • Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, et al. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med. 2007; 35: 1376-82.
    • (2007) Crit Care Med , vol.35 , pp. 1376-1382
    • Barraud, D.1    Faivre, V.2    Damy, T.3    Welschbillig, S.4    Gayat, E.5    Heymes, C.6
  • 51
    • 33947713478 scopus 로고    scopus 로고
    • Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: Alteration of force-frequency and relaxation-frequency relationships
    • Givertz MM, Andreou C, Conrad CH, Colucci WS. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships. Circulation. 2007; 115: 1218-24.
    • (2007) Circulation , vol.115 , pp. 1218-1224
    • Givertz, M.M.1    Andreou, C.2    Conrad, C.H.3    Colucci, W.S.4
  • 52
    • 27144485340 scopus 로고    scopus 로고
    • Effects of levosimendan on restrictive left ventricular filling in severe heart failure: A combined hemodynamic and Doppler echocardiographic study
    • Dernellis J, Panaretou M. Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study. Chest. 2005; 128: 2633-9.
    • (2005) Chest , vol.128 , pp. 2633-2639
    • Dernellis, J.1    Panaretou, M.2
  • 53
    • 1342267272 scopus 로고    scopus 로고
    • Successful use of levosimendan in a patient with peripartum cardiomyopathy
    • Benlolo S, Lefoll C, Katchatouryan V, Payen D, Mebazaa A. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg. 2004; 98: 822-4.
    • (2004) Anesth Analg , vol.98 , pp. 822-824
    • Benlolo, S.1    Lefoll, C.2    Katchatouryan, V.3    Payen, D.4    Mebazaa, A.5
  • 54
    • 40949165585 scopus 로고    scopus 로고
    • Peripartum cardiomyopathy: A new successful setting for levosimendan
    • in press
    • Benezet-Mazuecos J, de la Hera J. Peripartum cardiomyopathy: A new successful setting for levosimendan. Int J Cardiol. 2007; in press.
    • (2007) Int J Cardiol
    • Benezet-Mazuecos, J.1    de la Hera, J.2
  • 55
    • 34347400831 scopus 로고    scopus 로고
    • Levosimendan for post-partum cardiomyopathy
    • Nguyen HD, McKeown B. Levosimendan for post-partum cardiomyopathy. Crit Care Resusc. 2005; 7: 107-10.
    • (2005) Crit Care Resusc , vol.7 , pp. 107-110
    • Nguyen, H.D.1    McKeown, B.2
  • 57
    • 1342310815 scopus 로고    scopus 로고
    • Acute right ventricular failure-from pathophysiology to new treatments
    • Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure-from pathophysiology to new treatments. Intensive Care Med. 2004; 30: 185-96.
    • (2004) Intensive Care Med , vol.30 , pp. 185-196
    • Mebazaa, A.1    Karpati, P.2    Renaud, E.3    Algotsson, L.4
  • 59
    • 34548428716 scopus 로고    scopus 로고
    • Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: Importance of early use
    • Tasouli A, Papadopoulos K, Antoniou T, Kriaras I, Stavridis G, Degiannis D, et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg. 2007; 32: 629-33.
    • (2007) Eur J Cardiothorac Surg , vol.32 , pp. 629-633
    • Tasouli, A.1    Papadopoulos, K.2    Antoniou, T.3    Kriaras, I.4    Stavridis, G.5    Degiannis, D.6
  • 61
    • 0031795209 scopus 로고    scopus 로고
    • Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis
    • Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med. 1998; 158: 1076-81.
    • (1998) Am J Respir Crit Care Med , vol.158 , pp. 1076-1081
    • Monchi, M.1    Bellenfant, F.2    Cariou, A.3    Joly, L.M.4    Thebert, D.5    Laurent, I.6
  • 62
    • 0031767472 scopus 로고    scopus 로고
    • Hemodynamic profile in severe ARDS: Results of the European Collaborative ARDS Study
    • Squara P, Dhainaut JF, Artigas A, Carlet J. Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study. Intensive Care Med. 1998; 24: 1018-28.
    • (1998) Intensive Care Med , vol.24 , pp. 1018-1028
    • Squara, P.1    Dhainaut, J.F.2    Artigas, A.3    Carlet, J.4
  • 63
    • 25144511825 scopus 로고    scopus 로고
    • European experience on the practical use of levosimendan in patients with acute heart failure syndromes
    • Follath F, Franco F, Cardoso JS. European experience on the practical use of levosimendan in patients with acute heart failure syndromes. Am J Cardiol. 2005; 96: 80G-85G.
    • (2005) Am J Cardiol , vol.96
    • Follath, F.1    Franco, F.2    Cardoso, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.